1Z00

Solution structure of the C-terminal domain of ERCC1 complexed with the C-terminal domain of XPF

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D NOESY-(13C,1H)-HSQC	1.5mM ERCC1-XPF U-15N,13C; 50mM phosphate buffer NA: 92% H2O, 8% D2O	92% H2O, 8% D2O	50mM phosphate, 100mM NaCl	7.0	1 atm	295.5
2	3D NOESY-(15N,1H)-HSQC	1.5mM ERCC1-XPF U-15N,13C; 50mM phosphate buffer NA: 92% H2O, 8% D2O	92% H2O, 8% D2O	50mM phosphate, 100mM NaCl	7.0	1 atm	295.5
3	3D (13C)-HMQC-NOESY-(13C,1H)-HSQC	1.5mM ERCC1-XPF U-15N,13C; 50mM phosphate buffer NA: 92% H2O, 8% D2O	92% H2O, 8% D2O	50mM phosphate, 100mM NaCl	7.0	1 atm	295.5
4	3D (13C)-HMQC-NOESY-(15N 1H)-HSQC	1.5mM ERCC1-XPF U-15N,13C; 50mM phosphate buffer NA: 92% H2O, 8% D2O	92% H2O, 8% D2O	50mM phosphate, 100mM NaCl	7.0	1 atm	295.5
5	2D NOESY	1mM ERCC1-XPF U-15N; 50mM phosphate buffer NA: 92% H2O, 8% D2O	92% H2O, 8% D2O	50mM phosphate, 100mM NaCl	7.0	1 atm	295.5
6	2D NOESY 15N FILTERED	1mM ERCC1-XPF U-15N; 50mM phosphate buffer NA: 92% H2O, 8% D2O	92% H2O, 8% D2O	50mM phosphate, 100mM NaCl	7.0	1 atm	295.5

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	700
2	Bruker	AVANCE	900

NMR Refinement
Method	Details	Software
water refinment in CNS	4547 NOE-derived distance restraints, 197 TALOS based dihedral angle restraints and distance restraints for 52 hydrogen bonds	XwinNMR

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	XwinNMR	3.5
2	processing	NMRPipe	2.3	Delaglio
3	data analysis	Sparky	3.110	Goddard and Kneller
4	structure solution	CYANA	2.0	Guntert
5	refinement	CNS	1.1	Brunger

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.